Starch Softgel Capsules Market

Starch Softgel Capsules Market – Overview

The global starch softgel capsules market is projected to expand at a favorable rate from 2021 to 2031 (forecast period). The growing availability of vegetarian softgel capsules and the increased demand for softgel capsules from pharmaceutical and nutraceutical firms are expected to drive the expansion of the global starch softgel capsules market.

Starch soft gel capsules are often sourced from natural sources and utilized as nutritional supplements for people with a variety of medical ailments. Such soft gel capsules are typically free of genetic alterations and are produced in accordance with high-quality standards.

For vegetarians and non-vegetarians, soft gel capsules are available in both gelatin and non-gelatin formulations. Soft gels are a popular and commonly used oral dosage form for medications and nutraceuticals. In recent years, vegetarian softgel capsules have gained significant popularity in the global starch softgel capsules market. These capsules are an excellent and viable alternative for individuals who prefer not to take gelatin capsules.

Starch Softgel Capsules Market – Competitive Landscape

Major players operating in the global starch softgel capsules market are Hunan Er-Kang Pharmaceutical Co., Ltd., Sirio Pharma Co., Ltd., Catalent Inc, Procaps, Robinson Pharma, Inc., CAPTEK Softgel International Inc., Softcaps, Aenova Holding GmbH, Fuji Capsule Co., Ltd., and Bahrain Pharma.

To broaden and strengthen their worldwide presence, key market players are adopting marketing tactics such as investments, partnerships, technological innovations, R&D activities, and acquisitions.

Starch Softgel Capsules Market – Trends and Opportunities

The global starch softgel capsules market is expected to gain from the increasing demand for vegetarian softgel capsules. Aside from pharmaceutical drug delivery, vegetarian softgel capsules are commonly used to fill nutritional supplements.

The general consumer trend in the health industry is pointing to a rise in demand for natural products and novel ways of dose. Vegetarian softgels have a key advantage as they do not have any gelatin generated from animal waste. Vegetarians can use these starch softgels since they can be ingested without concern of animal illness or disease. The vegetarian softgels are chemically stable and have a low moisture content, which makes them less fragile even in low humidity. The Islamic Food and Nutrition Council of America has granted halal certification to companies that manufacture halal softgel capsules (IFANCA). This is projected to create a sizable market for these capsules in Muslim-majority countries.

The health supplements segment is expected to experience growth in the global starch softgel capsules market due to factors such as softgels' ability to cover odors, their exquisite appearance, and ease of ingesting. Moreover, such formulations are deemed optimal since they promote bioavailability and absorption of key nutrients. The most popular starch softgel health supplements are vitamin and mineral supplements. Furthermore, rising public awareness of the benefits of health and fitness and high use of sports-related health nutritional supplements are expected to fuel the segment's expansion.

The pharmacy and drugstore segment is projected to grow in the global starch softgel capsules market. Retail pharmacies are becoming one of the major sources of guidance in developing nations, including nutritional supplements and over-the-counter medicines. The segment is expected to grow in the next years as a result of a rising trend of collaboration between retailers and effective health systems for care assistance to patients leaving hospitals. On the other hand, the online providers segment is estimated to rise at a rapid pace during the projected period.

Starch Softgel Capsules Market – Regional Landscape

The starch softgel capsules market in Europe is expected to grow due to the growing availability of vegetarian softgel capsules and the growing demand for softgel capsules from pharmaceutical and nutraceutical firms.

Germany is likely to contribute significantly, owing to the rising incidence of chronic diseases and increased investment by market participants. Catalent, for example, extended its comprehensive turnkey softgel capabilities at its plant in Eberbach, Germany, in April 2019. This expansion cost the firm $14 million, and it features two new softgel encapsulation lines devoted to the company's Vegicaps technology. The starch softgel capsules market in Asia Pacific is anticipated to witness growth during the forecast period.